Every single second, the human bone marrow performs a biological feat of staggering proportions, generating millions of new blood and…
Read More
Tubulin Acts as a Molecular Chaperone to Prevent Toxic Protein Aggregation in Alzheimer’s and Parkinson’s Disease Research
Scientists at the Baylor College of Medicine have announced a significant breakthrough in the understanding of neurodegenerative pathologies, identifying a…
Read More
Genetic Mutations Shared by Cancer and Blood Cells Identified as Potential Drivers of Alzheimer’s Disease Pathogenesis
Recent breakthroughs in genomic sequencing have fundamentally altered our understanding of how the human body ages, revealing that the genetic…
Read More
Experimental Molecule OLE Identified as Potential Breakthrough in Restoring Microglial Function and Combating Alzheimers Disease
Researchers at the Institute for Neurosciences in Spain and the École Polytechnique Fédérale de Lausanne in Switzerland have announced the…
Read More
DNA Aptamers Offer a Promising New Frontier in Identifying and Targeting Senescent Cells for Aging and Disease Research
One of the most significant hurdles in unraveling the complexities of aging and a spectrum of diseases lies in the…
Read More
Scientists May Have Found What Really Triggers Alzheimer’s Disease
A groundbreaking study from the University of California, Riverside, suggests that the traditional understanding of Alzheimer’s disease may require a…
Read More
Marshall University Researchers Uncover Gut Exosomes as Key Contributors to Aging-Related Inflammation and Chronic Disease
Researchers at the Marshall University Joan C. Edwards School of Medicine have unveiled groundbreaking evidence suggesting that microscopic particles originating…
Read More
UniQure Secures Path to Regulatory Review for Groundbreaking Huntington’s Disease Gene Therapy After FDA Reversal
UniQure has announced a significant turning point in its pursuit of regulatory approval for AMT-130, a pioneering gene therapy aimed…
Read More
ETH Zurich Researchers Identify Breakthrough Compound 10 as a Potential New Frontier in Alzheimer’s Disease Treatment and Neuroprotection
A multidisciplinary research team at ETH Zurich has announced the discovery of a novel experimental substance, currently designated as Compound…
Read More
Traumatic brain injury and Alzheimer’s disease, common neuroinflammatory pathologies and therapeutic potential
Traumatic brain injury (TBI) represents a formidable global public health challenge, impacting an estimated 69 million individuals each year across…
Read MoreYOU MAY HAVE MISSED
